The Weekly Roundup: January 20 – 24

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Insights from a Dermatologist with Urticaria: Jason Hawkes, MD, MS

Hawkes combines personal experience and clinical expertise to treat urticaria patients.

Secukinumab Demonstrates Long-Term Safety and Efficacy in Pediatric Patients with GPP

In a real-world study, 10 children with generalized pustular psoriasis saw sustained improvements up to 160 weeks.

When and How to Employ the Buy and Bill Model

Noor emphasizes that patient access is the primary consideration when deciding to use the buy-and-bill model.

Nutraceutical Supplement Effective and Safe for Male Hair Thinning

When compared to the placebo, hair growth and quality significantly improved by day 180.

POLL: What Topics and Content Would You Like to See More of From Us?

Share your thoughts and help shape our content by telling us what topics you want to see more of this year.

Study Explores Psoriasis-Dementia Link

A recent study found chronic inflammation in psoriasis may contribute to cognitive decline.

VP-315 Demonstrates Positive Topline Results in Basal Cell Carcinoma

Three posters supporting VP-315's treatment efficacy and outcomes were presented at the Winter Clinical Miami conference.

Advances in Urticaria Care with Jason Hawkes, MD, MS

Fast-acting therapies like remibrutinib bring new hope to patients with chronic urticaria who don’t respond to antihistamines.

Micro-Coring Revolutionized: Cytrellis' Denise Dajles, DEng, MSc, on Evolving Skin Treatments with Ellacor 2.0

Ellacor 2.0 offers advanced micro-coring technology, streamlined protocols, and faster results for non-surgical skin rejuvenation.

Systemic Review Compares Types of Dermal Fillers for Acne Scarring

Although HA and other methods are safe, more reliable data is needed to determine which is most effective.

OS-01 Peptide Product Can Reduce Signs of Periorbital Skin Aging

Patients saw notable improvements in skin hydration, firmness, elasticity, and radiance after 4 and 12 weeks.

Denise Dajles, DEng, MSc, Ushers in a New Era at Cytrellis Biosystems, Looks to Future of Aesthetics Industry

Cytrellis' new president and CEO discusses bridging surgery and innovation in aesthetics.

Optimizing Care for Patients with Urticaria

Jason Hawkes, MD, MS, discusses unmet needs in chronic urticaria care and challenges outdated testing practices.

IPL and BoNT/A Synergy for Rosacea

Researchers found the combination therapy significantly reduced rosacea severity, with 64% achieving mild or normal status in just 4 weeks.

Pediatric Patients with Atopic Dermatitis Have Lower SCH and Higher TEWL, Compared to Those Without

Researchers analyzed stratum corneum hydration and transepidermal water loss across 15 regions of the skin.

Clinical Validation Reached in Phase 2a Trial of AX-158 for Psoriasis

These efficacy results and safety profile confirm what was observed in phase 1 study.

Developing an OTC Dermatology Product

Renata Block, MMS, PA-C, and Erica Ramos, PA-C, discuss the complexities of developing an over-the-counter hair product.

Exploring Oral Therapies for Hyperhidrosis: Current and Future Perspectives

Adam Friedman, MD, FAAD, takes a closer look at the emerging landscape of oral treatments for hyperhidrosis and what lies ahead in advancing patient care.

First Patient Dosed in Phase 1 Study of Attovia's ATTO-1310 for Chronic Pruritus

Attovia is also advancing 4 ATTOBODY-based programs for inflammatory conditions, such as atopic dermatitis and IBD.

James Del Rosso, DO, on What’s New in the Medicine Chest

In his presentation at Winter Clinical Miami, Del Rosso covered new and emerging therapies as well as successful off-label uses.

Patricia Farris, MD, on AP31’s Anti-Aging Power

AP31, a novel micropeptide, delivers anti-aging and anti-inflammatory benefits, improving skin firmness, lifting, and reducing wrinkles.

CT-P39 is Just as Effective as Omalizumab for Chronic Spontaneous Urticaria Treatment

According to a phase 3 study, the omalizumab biosimilar saw comparable results with a good safety profile.

Novel RF and HIFES Device is Effective for Enhancing Facial Laxity Among Asian Patients

Combining synchronized radiofrequency with high intensity facial electrical stimulation led to firmer, smoother, and more lifted skin.

Reviewing Complex Cases: Psoriasis in Older Patients

At the Horizons in Advanced Practice meeting, Omar Noor, MD, FAAD, presented a case of a man aged 70 years with a 20-year history of psoriasis who was previously treated with adalimumab.

Guidelines, Testing, and Future Directions in Urticaria

Understanding urticaria subtypes, from spontaneous to inducible, is key to crafting patient-specific management plans.

Pearls for Treatment Selection and Managing Adverse Effects in Hyperhidrosis

Personalized care is key to managing hyperhidrosis, blending therapies, addressing adverse effects, and empowering patients with tailored solutions.

Additional Evidence Supports Quoin’s QRX003 for Netherton Syndrome

QRX003 mimics the LEKTI protein to strengthen skin barriers and alleviate symptoms in patients with Netherton Syndrome.

Combining Minoxidil and LLLT Does Not Improve Treatment Outcomes for Androgenic Alopecia

Compared to minoxidil alone, the combination therapy saw no significant differences in hair count and diameter.

The Skin Smart Campus Initiative: Promoting Skin Health and Public Awareness at GW

George Washington University recently earned a Skin Smart Campus designation, championing skin cancer prevention through education, free sunscreen, and UV safety measures.

New Cysteamine and Isobionicamide Formulation Can Rejuvenate Aging Skin

More luminous skin with reduced fine lines and hyperpigmentation was seen as early as 2 weeks.